CA2102196A1 - 5-aminoquinolone carboxylic acid derivative and antibacterial agent containing the same as active ingredient - Google Patents

5-aminoquinolone carboxylic acid derivative and antibacterial agent containing the same as active ingredient

Info

Publication number
CA2102196A1
CA2102196A1 CA002102196A CA2102196A CA2102196A1 CA 2102196 A1 CA2102196 A1 CA 2102196A1 CA 002102196 A CA002102196 A CA 002102196A CA 2102196 A CA2102196 A CA 2102196A CA 2102196 A1 CA2102196 A1 CA 2102196A1
Authority
CA
Canada
Prior art keywords
carboxylic acid
linear
branched alkyl
carbon atoms
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002102196A
Other languages
English (en)
French (fr)
Inventor
Terumitsu Kaihoh
Sunao Takeda
Fujiko Konno
Akihiro Shibata
Masaru Matsumoto
Takemitsu Asaoka
Hideaki Matsuda
Tadayuki Kuraishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2102196A1 publication Critical patent/CA2102196A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CA002102196A 1992-05-26 1993-05-25 5-aminoquinolone carboxylic acid derivative and antibacterial agent containing the same as active ingredient Abandoned CA2102196A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP133394/1992 1992-05-26
JP13339492 1992-05-26

Publications (1)

Publication Number Publication Date
CA2102196A1 true CA2102196A1 (en) 1993-11-27

Family

ID=15103727

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002102196A Abandoned CA2102196A1 (en) 1992-05-26 1993-05-25 5-aminoquinolone carboxylic acid derivative and antibacterial agent containing the same as active ingredient

Country Status (5)

Country Link
US (1) US5430028A (en, 2012)
EP (1) EP0601197A4 (en, 2012)
CA (1) CA2102196A1 (en, 2012)
TW (1) TW222272B (en, 2012)
WO (1) WO1993024460A1 (en, 2012)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6685958B2 (en) 2001-04-25 2004-02-03 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
US6699492B2 (en) 1999-03-31 2004-03-02 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
BRPI0717513A2 (pt) * 2006-10-06 2013-11-19 Bausch & Lomb Processo para preparar um composto, enantiômero isolado de uma fluoroquinolona, uso do enantiômero isolado, e, composição oftálmica
US7632944B2 (en) 2007-01-24 2009-12-15 Bausch & Lomb Incorporated Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
US8252783B2 (en) 2007-01-24 2012-08-28 Bausch & Lomb Incorporated Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
US20090082337A1 (en) * 2007-09-21 2009-03-26 Srini Venkastesh Compositions Comprising Quinolone and Methods for Treating or Controlling Infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3420743A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
AU594983B2 (en) * 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof
US4668680A (en) * 1985-12-12 1987-05-26 Warner-Lambert Company 5-amino-6,8-difluoroquinolones as antibacterial agents
JPS62215572A (ja) * 1986-03-17 1987-09-22 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
JPS63275567A (ja) * 1987-05-07 1988-11-14 Dainippon Pharmaceut Co Ltd 新規キノリン誘導体、そのエステルおよびその塩
AU618823B2 (en) * 1988-07-20 1992-01-09 Sankyo Company Limited 4-oxoquinoline-3-carboxylic acid derivatives, their preparation and their use
JP2613139B2 (ja) * 1990-07-19 1997-05-21 エスエス製薬 株式会社 キノロンカルボン酸誘導体

Also Published As

Publication number Publication date
EP0601197A1 (en) 1994-06-15
TW222272B (en, 2012) 1994-04-11
WO1993024460A1 (fr) 1993-12-09
EP0601197A4 (en) 1994-10-26
US5430028A (en) 1995-07-04

Similar Documents

Publication Publication Date Title
US5385900A (en) Quinoline carboxylic acid derivatives
GB2057440A (en) Quinoline carboxylic acid derivatives
KR930005002B1 (ko) 피리돈카복실산 유도체의 제조방법
KR920006236B1 (ko) 퀴놀론카복실산 유도체의 제조방법
US4429127A (en) Quinoline carboxylic acid derivative
EP0115049B1 (en) 1-ethyl-6,8-difluoro-1,4-dihydro-7-(1-imidazolyl)-4-oxoquinoline-3-carboxylic acid derivatives, process for preparing the same and anti-microbial compositions
CA1256876A (en) 7-(1-pyrrolyl) derivatives of substituted 1-ethyl-1,4- dihydro-4-oxoquinoline-3-carboxylic acids and substituted 1-ethyl-1,4-dihydro-4-oxo-1,8- naphthyridine-3-carboxylic acids,their preparation and their application as drugs
JPH02282384A (ja) ５―置換―１，４―ジヒドロ―４―オキソ―１，８―ナフチリジン―３―カルボキシラート抗菌剤
CA2102196A1 (en) 5-aminoquinolone carboxylic acid derivative and antibacterial agent containing the same as active ingredient
EP0178388A1 (en) Quinolinecarboxylic acid derivatives
EP0207497A2 (en) Quinolonecarboxylic acid derivative and process for its preparation
JPH0717608B2 (ja) ６−アルコキシキノロンカルボン酸誘導体
KR930003611B1 (ko) 퀴놀론 카복실산 유도체의 제조방법
US4720495A (en) Benzo[ij]quinolizine-2-carboxylic acids useful for treating bacterial infection
PH26759A (en) 4-oxo-3-quinolinecarboxylic acids pharmaceutical composition containing said compound and method of use thereof
EP0364943A2 (en) Benzoheterocyclic compounds
JPS62108878A (ja) キノロンカルボン酸誘導体およびその製造方法
KR950005201B1 (ko) 8-알콕시퀴놀론카복실산 유도체
KR100234546B1 (ko) 피리돈 카르복실산 유도체 및 그의 제조방법
DE68905222T2 (de) 7-(1-imidazolyl)-1,4-dihydro-4-oxo-6,8-difluoro-1-cyclopropylchinolincarbonsaeure-derivate, ihre herstellung und ihre verwendung als arzneimittel.
KR910003186B1 (ko) 항균작용을 갖는 퀴놀론계 유도체와 그의 제조방법
IT8322311A1 (it) 7-(4-piridil)-1,8-naftiridin-derivati
KR940009786B1 (ko) 새로운 퀴놀론계 항균제
JP2621204B2 (ja) 抗菌化合物
JPH0641084A (ja) ５−アミノキノロンカルボン酸誘導体及びこれを有効成分とする抗菌剤

Legal Events

Date Code Title Description
FZDE Discontinued